Evidence map›Paper›PMID 33568785›Full record

ArticleMucosal immunology2021

Metabolic activation and colitis pathogenesis is prevented by lymphotoxin β receptor expression in neutrophils.

Thomas Riffelmacher, Daniel A Giles, Sonja Zahner, Martina Dicker, Alexander Y Andreyev, Sara McArdle, Tamara Perez-Jeldres, Esmé van der Gracht, Mallory Paynich Murray, Nadine Hartmann and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Mucosal immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Role of Mitochondria in Inflammatory Bowel Diseases: A Systematic Review.International journal of molecular sciences · 2023
    Pooled it
  2. Article
  3. Lymphotoxin beta receptorInfection and immunity · 2025
    Article
  4. Review
  5. Review
  6. Mediators of inflammation · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. An epithelialProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Thomas Riffelmacher *La Jolla Institute for Immunology, La Jolla, CA, USA.
Daniel A Giles *La Jolla Institute for Immunology, La Jolla, CA, USA.
Sonja ZahnerLa Jolla Institute for Immunology, La Jolla, CA, USA.
Martina DickerLa Jolla Institute for Immunology, La Jolla, CA, USA.
Alexander Y AndreyevDepartment of Pharmacology, University of California San Diego, La Jolla, CA, USA.
Sara McArdleLa Jolla Institute for Immunology, La Jolla, CA, USA.
Tamara Perez-JeldresLa Jolla Institute for Immunology, La Jolla, CA, USA.
Esmé van der GrachtLa Jolla Institute for Immunology, La Jolla, CA, USA.
Mallory Paynich MurrayLa Jolla Institute for Immunology, La Jolla, CA, USA.
Nadine HartmannLa Jolla Institute for Immunology, La Jolla, CA, USA.
Alexei V TumanovDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center San Antonio, San Antonio, USA.
Mitchell KronenbergLa Jolla Institute for Immunology, La Jolla, CA, USA. mitch@lji.org.
La Jolla Institute for Immunology · USUniversity of California, San Diego · USThe University of Texas Health Science Center at San Antonio · USUniversity of Oxford · GB

Funding

Using polygenic scores to enhance both variant discovery, and understanding of functional consequences of genetic variation in IBD.P01DK046763 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI MCGOVERN, DERMOT PATRICK · 1992 to 2020
$31.1M
The role of LIGHT in Colitis PathogenesisR01AI061516 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2004 to 2015
$4.5M
Training in Immunological MechanismsT32AI125179 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2016 to 2025
$3.1M
HVEM: A TNF family receptor that influences mucosal immunity and the microbiomeU01AI125955 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2016 to 2020
$2.7M
The role of natural killer T cells in the innate response to lung infectionR01AI105215 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2014 to 2018
$2.2M
Super-resolution confocal microscopeS10OD021831 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI LEY, KLAUS F. · 2017 to 2017
$566k
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
Innate lymphoid cells in Campylobacter-induced colitisR21AI135574 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI TUMANOV, ALEXEI V · 2018 to 2019
$419k
The role of GPR183 in Inflammatory Bowel Disease pathogenesisF32AI140581 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI GILES, DANIEL AARON · 2018 to 2019
$89k
Austrian Science Fund FWF J 4308NCRR NIH HHS S10 RR027366NIAID NIH HHS F32 AI140581NIAID NIH HHS R01 AI061516NIAID NIH HHS R01 AI105215NIAID NIH HHS R21 AI135574NIAID NIH HHS T32 AI125179NIAID NIH HHS U01 AI125955NIDDK NIH HHS P01 DK046763NIH HHS S10 OD021831Wellcome Trust 210842/Z/18/ZWellcome Trust 210842_Z_18_Z
6 · The paper itself

Abstract

Inflammatory bowel disease is characterized by an exacerbated intestinal immune response, but the critical mechanisms regulating immune activation remain incompletely understood. We previously reported that the TNF-superfamily molecule TNFSF14 (LIGHT) is required for preventing severe disease in mouse models of colitis. In addition, deletion of lymphotoxin beta receptor (LTβR), which binds LIGHT, also led to aggravated colitis pathogenesis. Here, we aimed to determine the cell type(s) requiring LTβR and the mechanism critical for exacerbation of colitis. Specific deletion of LTβR in neutrophils (LTβR

Indexed as

Activation, MetabolicAnimalsColitisDextran SulfateDisease Models, AnimalDisease ProgressionHumansInflammatory Bowel DiseasesLymphotoxin beta ReceptorMiceMice, Inbred C57BLMice, KnockoutMitochondriaNeutrophilsTumor Necrosis Factor Ligand Superfamily Member 14Dextran SulfateLymphotoxin beta ReceptorTumor Necrosis Factor Ligand Superfamily Member 14

Identifiers

PMID33568785
PMCPMC8075978
OpenAlexW3127855223

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.